NCT03190785

Brief Summary

The benzoic acid derivatives sodium and potassium benzoate are preservatives that are commonly added to food and beverages to inhibit microbial growth and prevent spoilage. In the US the major source of benzoate intake is beverages. Studies have shown that piglets or chicks fed low levels of benzoic acid have greater feed efficiency and gain more weight than control fed animals. It has also been shown that benzoic acid inhibits the release of a key metabolic hormone, leptin, from isolated adipocytes (fat cells). Inadequate leptin levels result in increased appetite, decreased metabolic rate, weight gain, insulin resistance and increased diabetes risk. The primary aim of the proposed research is to directly determine if benzoate consumption in human volunteers results in lower levels of leptin, decreased metabolic rate and increased insulin resistance. If so this would implicate benzoic acid as an obesogen and would help inform more effective approaches to obesity prevention and treatment. A secondary aim of the study is to establish a connection between benzoate exposure and biomarkers in urine that can be used to help treat obese patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 19, 2017

Completed
12 days until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

March 24, 2023

Status Verified

March 1, 2023

Enrollment Period

3.7 years

First QC Date

June 13, 2017

Last Update Submit

March 23, 2023

Conditions

Keywords

benzoic acidendocrine disrupting chemicalsleptinmetabolic rate

Outcome Measures

Primary Outcomes (1)

  • Metabolic rate

    Metabolic rate as measured by indirect calorimetry

    measured following 1 week dietary exposure to benzoic acid.

Secondary Outcomes (1)

  • Leptin levels

    measured following 1 week dietary exposure to benzoic acid

Study Arms (1)

Benzoic acid washout and exposure

EXPERIMENTAL

All subjects will be in this arm which employs a pre-post exposure design. Subjects will undergo a 2 week washout period where they avoid consumption of benzoate containing beverages. Then there is a 1 week exposure period comprising daily consumption of benzoate containing beverages to result in up to 5 mg/kg per day benzoic acid intake.

Other: Benzoic acid washout and exposure

Interventions

see above

Benzoic acid washout and exposure

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Young adult (18-30 yrs)
  • Healthy non-smoker
  • Either overweight (BMI \>25 but \<30) or obese (BMI \>30)
  • Has or can obtain transportation to study site
  • Able to provide written consent in English

You may not qualify if:

  • Metabolic disease
  • Diabetes mellitus
  • Hypothyroidism
  • Use of medication that may influence metabolism
  • Anti-hyperglycemic agents
  • Thyroid hormone
  • Stimulants for ADD/ADHD
  • Atypical anti-psychotics
  • Weight loss medications
  • Benzoate sensitivity
  • Known pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brody School of Medicine at East Carolina University

Greenville, North Carolina, 27834, United States

Location

MeSH Terms

Conditions

ObesityMetabolic Syndrome

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pre/post exposure comparison
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Pediatrics

Study Record Dates

First Submitted

June 13, 2017

First Posted

June 19, 2017

Study Start

July 1, 2017

Primary Completion

March 1, 2021

Study Completion

April 1, 2021

Last Updated

March 24, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations